The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular prescreening (MP) to treat patients (pts) with advanced pancreatic cancer (PC) in early clinical trials.
 
Tamara Sauri
No Relationships to Disclose
 
Teresa Macarulla
No Relationships to Disclose
 
Guadalupe Cabrera
No Relationships to Disclose
 
Helena Verdaguer
No Relationships to Disclose
 
Jorge Zeron-Medina
No Relationships to Disclose
 
Ana Vivancos
No Relationships to Disclose
 
Jaume Capdevilla
No Relationships to Disclose
 
Elena Elez
No Relationships to Disclose
 
Maria Alsina
No Relationships to Disclose
 
Guillem Argiles
No Relationships to Disclose
 
Cinta Hierro
No Relationships to Disclose
 
Julieta Grasselli
No Relationships to Disclose
 
Ignacio Matos
No Relationships to Disclose
 
Jordi Rodon
No Relationships to Disclose
 
Paolo Nuciforo
No Relationships to Disclose
 
Rodrigo Dienstmann
No Relationships to Disclose
 
Josep Tabernero
Consulting or Advisory Role - Amgen; Celgene; Chugai Pharma; ImClone Systems; Lilly; Merck KGaA; Millennium; Novartis; Roche/Genentech; Sanofi; Symphony Evolution; Taiho Pharmaceutical